You are here

Eli Lilly

Eli Lilly strikes 2nd deal to boost affordable insulin access, this time in Bangladesh

Fierce Pharma

Mon, 02/13/23 - 10:21 am

Eli Lilly's employment decisions under fire once again as sales rep lodges age discrimination claim

Fierce Pharma

Thu, 02/9/23 - 06:38 pm

age discrimination

Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst

Fierce Pharma

Tue, 02/7/23 - 12:00 pm

Vertex Pharmaceuticals

IgGenix sprints to clinic with peanut allergy candidate and additional $40M

Endpoints

Mon, 02/6/23 - 06:15 pm

Lilly reports fast sales for new diabetes drug

BioPharma Dive

Thu, 02/2/23 - 11:07 pm

Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials

Medical Marketing and Media

Thu, 02/2/23 - 10:55 am

Bristol Myers Squibb

Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3

Fierce Pharma

Tue, 01/31/23 - 12:31 pm

Teva Pharmaceutical

clinical trials

Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma

Endpoints

Sun, 01/29/23 - 02:14 pm

mantle cell lymphoma

Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility

Medical Marketing and Media

Tue, 01/24/23 - 06:34 pm

drug manufacturing

Some Experts Say FDA Made the Right Call on Lilly's Donanemab

BioSpace

Tue, 01/24/23 - 10:31 am

Alzheimer's disease

This Week at FDA: Pallone pushes for greater ClinicalTrials.gov enforcement, FDA rejects Eli Lilly Alzheimer’s drug, and more

RAPS.org

Sun, 01/22/23 - 01:00 pm

clinical trials

clinicaltrials.gov

Innovative Trial Design may have Cost Lilly’s Donanemab Accelerated Approval

BioSpace

Fri, 01/20/23 - 10:29 am

clinical trials

Alzheimer's disease

clinical trial design

Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer's drug

Yahoo/Reuters

Thu, 01/19/23 - 09:00 pm

Alzheimer's disease

A year of two halves for US approvals

EP Vantage

Thu, 01/19/23 - 09:38 am

Bristol Myers Squibb

Biopharma's stock market winners of 2022 revealed

EP Vantage

Wed, 01/18/23 - 09:46 am

Vertex Pharmaceuticals

Sarepta Therapeutics

Horizon Therapeutics

AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks

ABPI

Tue, 01/17/23 - 10:38 am

Alzheimer’s disease trials: How does Lilly’s donanemab compare to lecanemab?

Clinical Trials Arena

Fri, 01/13/23 - 10:49 am

clinical trials

Alzheimer's disease

JPM23: Amid launch spree, Eli Lilly expects revenue growth at the 'high end of the industry,' CFO says

Fierce Pharma

Thu, 01/12/23 - 10:27 am

Lilly, Biogen and more gear up for blockbuster launches in 2023: report

Fierce Pharma

Wed, 01/11/23 - 11:00 pm

Bristol Myers Squibb

Pages